Tanne Corneal Cutting Block

Inquire

Inquire

Inquire

Optimal for Subcellular Fractionation, Proteins and Viruses • 64,000 x g (30,000 rpm) with fixed-angle rotor • Spin tubes from 0.25 up to 85 mL • Operating temperature from 2° C to

(Date:12/3/2008)...ewswire-FirstCall/ -- Forest Laboratories, Inc. (N...fied of an unsolicited mini-tender offer by TRC Ca...ate investment company. Forest Laboratories has r...to 3.0 million outstanding shares of the company,s...nt of its outstanding shares. The offer price of ...

(Date:12/3/2008)... 3 MAP,Pharmaceuticals,...ompany, will,participate in a panel discussion ti...t Conditions" at the 2008 RBC Capital Markets Heal..., at 10:00 am (ET) in New York City. , A li...le on the Investor,Relations section of MAP Pharm...

(Date:12/3/2008)...ellastim, an animal-free recombinant albumin produ... and human derived serum in CHO cell culture. , ...cember 3, 2008 -- Cellastim has proven to be a rob...edia and can improve both the growth kinetics and ... chemically defined media. , , ,Studies support In...

(Date:12/3/2008)... As previously announced,...ned subsidiary, WebMD Health Corp. (Nasdaq: WBMD...holders beginning at 9:30 a.m. Eastern Time on Wed...io webcast of the meetings will be available over ...e meetings, investors can go to www.hlth.com (in...

...a medication commonly prescribed to alleviate symp... effective than a placebo, according to a study// ... Center. “There was no benefit at all, and there ...ys lead author Thomas Neylan, MD, medical director...

...child with an eating disorder - monitoring meals, ...ut two new studies from researchers at the Stanfor...rd Children's Hospital indicate a need for increas... adolescents with the condition, and pre-teen weig...

...ho once treated mainly elderly patients for health...ke are seeing increasingly// younger patients who ...issue of Mayo Clinic Proceedings focuses on the in...ome, a state characterized by cardiovascular risk ...

...dertake a long-term weight training program produc...ng that allows physiologists //to understand why w...metabolic function. A study published in the Dece...Physiology-Endocrinology and Metabolism looked at ...

(Date:12/2/2008)...izon Therapeutics, Inc., a,privately held biophar...al,Phase 3 trials evaluating its lead investigati...endpoints. HZT-501, a novel, proprietary fixed-dos...motidine, demonstrated a,statistically significan...i-inflammatory drug (NSAID)-induced upper gastroin...

(Date:12/1/2008)...-- New research has found that the availability of...canner in an emergency room can significantly incr...tentially life-saving treatment. Results of the st...)-Salem Hospital in Salem, Mass., will be presente...Society of North America (RSNA). , , "The h...

(Date:12/1/2008)...Call/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VND...e world,s leading medical journals, results of cli...erimental compound tasimelteon (VEC-162). The pub...onin agonist tasimelteon (VEC-162) for transient i...trolled multicentre trials." Results are reported ...

(Date:12/1/2008)...Pte Ltd today announced the initiation of a Phase ...active JAK2 inhibitor, in leading medical centers ...myelofibrosis (CIMF). , , The trial is des...B1518 in patients with CIMF and is expected to enr...dy will assess the safety profile and evaluate the...

...ercentage of Working Age People with Diabetes, Hos...and National Averages, PITTSBURGH, April 02, 2007 ...Group on Health (PBGH) announced today the,release...ity of,care for people with Type 2 diabetes. The i...6 presents an overview of patient,demographics, ho...

...hed in Vaccine Shows Strong Immune Response, Prote...., April 02, 2007 /PRNewswire-FirstCall/ -- Novava...red a robust immune,response and provided protecti...ording to pre- clinical data published in the onli...cine was tested in three animal models, including,...